SINGAPORE: The parents of a 14-month-old baby named Shamel are appealing to people’s hearts to help raise money for medical treatment to fight a rare genetic condition he was diagnosed with last November. The cost for Zolgensma, a one-time gene therapy to treat Shamel’s type 2 Spinal Muscular Atrophy (SMA) costs approximately S$3,016,229.20. Shamel, the … Continue reading Crowdfunding effort to raise $3million launched to help 14-month-old boy fight rare genetic condition